U.S. Transportation Stock News

Wondering if ASML Holding at around US$1,516.60 is priced for perfection or still offers value? This article breaks down what the current share price really implies for you. The stock has returned 5.4% over the last week, 16.1% over the last month, 30.3% year to date and 115.6% over the past year, which naturally raises questions about where value and risk now sit. Recent coverage around ASML has emphasized its central role in semiconductor equipment and its importance to chip manufacturing...

Wondering whether Citizens Financial Group stock still offers value after its strong run, or if most of the easy gains are already behind it? This article walks through the key signals you can use to make that call. The stock last closed at US$64.22, with returns of 4.3% over 30 days, 8.1% year to date and 70.0% over 1 year, which can change how the market views both its growth potential and its risk profile. Recent coverage has focused on Citizens Financial Group's positioning as a major US...

Pomerantz LLP has opened an investigation into CarMax (NYSE:KMX) for potential securities fraud or other unlawful business practices. The inquiry follows CarMax's April 14, 2026 decision to lower used car prices and accept higher credit risk in response to an auto affordability crisis. The combination of a pricing shift and looser credit standards raises questions about risk management, disclosure, and long term business impacts. CarMax runs one of the largest used car retail operations in...

If you are wondering whether BioMarin Pharmaceutical's current share price reflects its true value, a useful starting point is understanding how the market has treated the stock recently. BioMarin's share price closed at US$54.12, with returns of 0.4% over 7 days, a 3.7% decline over 30 days, a 9.0% decline year to date, and a 9.5% decline over the last year, alongside longer term 43.3% and 28.3% declines over 3 and 5 years. These returns suggest many investors are likely reassessing whether...

This article examines whether Coty, trading at around US$2.50, may represent a bargain or a value trap by exploring what the current price could be implying about the stock. Coty's share price has moved by 1.6% over the last week and 18.5% over the last month. However, the stock is still showing a year to date return of a 19.6% decline and a 1 year return of a 48.1% decline. Recent news around Coty has focused on its positioning as a global beauty company, including ongoing brand activity...

If you are wondering whether Teledyne Technologies at around US$630 per share offers fair value or is pricing in too much optimism, the valuation picture is not as straightforward as the headline price suggests. The stock has seen a 2.3% decline over the last 7 days and a 0.7% decline over the last 30 days, while still sitting on returns of 21.6% year to date and 30.9% over the past year. Recent attention on Teledyne often centers on its position in high tech sensing, imaging and defense...

Palladyne AI Corp. recently reported past first-quarter 2026 results with revenue rising to US$3.54 million from US$1.71 million a year earlier, while swinging to a net loss of US$12.61 million and reaffirming full-year 2026 revenue guidance of US$24 million to US$27 million. The company also disclosed a roughly US$17 million backlog and new defense and space contracts, underlining growing demand for its embodied AI and autonomous systems offerings. Next, we’ll examine how reaffirmed...

What the latest guidance shift means for American Healthcare REIT (AHR) American Healthcare REIT (AHR) cut its 2026 net income guidance while highlighting a ninth straight quarter of double-digit same-store NOI growth and higher NFFO expectations, providing a mixed but detailed update on its outlook. See our latest analysis for American Healthcare REIT. Recent guidance cuts on 2026 net income sit alongside raised same store NOI and NFFO outlook, and the stock’s 1 month share price return of...

Century Aluminum (CENX) put up steady top line numbers in FY 2025, with fourth quarter revenue of US$633.7 million and basic EPS of US$0.02, capping a trailing twelve month run of US$2.5 billion in revenue and EPS of US$0.42. Over the past reported periods, quarterly revenue has moved in a tight band between US$628.1 million and US$633.9 million, while basic EPS has ranged from a quarterly loss of US$0.05 to a high of US$0.30. This sets up a story where investors are weighing solid revenue...

Why CSG Systems International Is On Investors’ Radar Today CSG Systems International (CSGS) is drawing attention after a period of steady share price performance, leaving investors weighing how its current valuation lines up with recent returns and fundamentals. See our latest analysis for CSG Systems International. At a share price of $80.39, CSG Systems International has seen relatively steady short term share price returns. A 1 year total shareholder return of 25.55% and 5 year total...

If you are wondering whether BioCryst Pharmaceuticals, at a last close of US$8.90, still offers value, it helps to step back and look at the full valuation picture rather than just the recent share price. The stock is up 18.7% year to date, although it has seen a 2.8% decline over the last week and a 7.2% decline over the last month, and the 1 year return sits at a 10.3% decline. Recent news coverage has focused on BioCryst Pharmaceuticals' pipeline progress and its positioning within the...

Nextpower (NasdaqGS:NXT) has appointed Lindsey Wiedmann as its new Chief Legal and Compliance Officer. Wiedmann steps in following the retirement of Bruce Ledesma from the role. She previously held senior legal and compliance responsibilities at Maxeon Solar Technologies, bringing sector specific experience. For readers tracking NasdaqGS:NXT, this shift in leadership comes at a time when solar and broader clean energy businesses are closely watched for how they handle regulation, policy...

Event context and recent share performance Andersen Group (ANDG) recently drew investor interest after a session that left the stock at $35.98, with single day and past week returns of 2.27% and 1.70% respectively. Over the past month and past 3 months, Andersen Group has delivered returns of 25.58% and 67.97%, while year to date the stock shows a 47.58% total return. See our latest analysis for Andersen Group. For context, Andersen Group's recent 1 month share price return of 25.58% and 3...

StandardAero (SARO) has wrapped up FY 2025 with fourth quarter revenue of US$1.6b and basic EPS of US$0.24, supported by trailing 12 month revenue of US$6.1b and EPS of US$0.84 that sit against a very large reported earnings expansion over the past year. The company has seen quarterly revenue move from US$1.41b in Q4 2024 to US$1.60b in Q4 2025, while basic EPS shifted from a loss of US$0.04 to a profit of US$0.24 over the same period, with trailing net profit margins now framed against a...

IDEX Corporation previously announced that its Board approved a regular quarterly cash dividend of US$0.73 per share, payable June 5, 2026 to shareholders of record on May 22, 2026, while also reporting first‑quarter 2026 sales of US$886.9 million and net income of US$120 million. This combination of higher quarterly earnings and the company’s 126th consecutive regular dividend, alongside continued share repurchases, underscores a consistent focus on shareholder returns. We’ll now explore...

Dropbox (DBX) has wrapped up FY 2025 with fourth quarter revenue of US$636.2 million and basic EPS of US$0.43, alongside trailing 12 month revenue of about US$2.5 billion and EPS of US$1.89 that frame the full year picture. Over the past six quarters in the data provided, quarterly revenue has moved between US$624.7 million and US$643.6 million, while basic EPS has ranged from US$0.34 to US$0.52, giving you a clear view of how the top line and per share earnings have tracked together. For...

If you are wondering whether Prestige Consumer Healthcare is attractively priced or just a value trap, the stock's recent performance and fundamentals give you plenty to weigh up. The share price recently closed at US$54.59, with returns of a 3.1% decline over 7 days, a 1.9% decline over 30 days, a 10.8% decline year to date, and a 37.3% decline over the last year, while the 3 year and 5 year returns stand at a 6.4% decline and 12.3% respectively. Recent coverage has focused on Prestige...

If you are wondering whether Advance Auto Parts stock still offers value at current levels, it helps to line up its recent returns with what the fundamentals and valuation checks are actually saying. The stock last closed at US$57.23, with returns of 8.7% over the past 30 days, 47.2% year to date and 85.9% over the past year, while the 3 year and 5 year returns of negative 51.1% and negative 68.4% show a very different experience for longer term holders. Recent news around Advance Auto Parts...

Immatics stock in focus Immatics (NasdaqCM:IMTX) is drawing attention after recent share price moves, with the stock last closing at US$11.14 and showing positive total returns over the past year and the past 3 months. See our latest analysis for Immatics. Recent moves fit a bigger pattern, with a 30 day share price return of 8.68% and a 90 day share price return of 15.68%, alongside a very large 1 year total shareholder return of 156.68%. These figures point to building momentum. If you are...

Investors may be wondering whether CONMED at around US$38.10 is starting to offer value, or if the stock’s long slide still reflects unresolved risks. The share price recently closed at US$38.10, with a 3.9% move over 7 days and 10.3% over 30 days, against a year to date return of a 6.0% decline and a 1 year return of a 33.5% decline that sits on top of a 68.0% decline over 3 years and a 71.8% decline over 5 years. Those long term returns have sharpened focus on how investors are assessing...

AngloGold Ashanti (NYSE:AU) capped FY 2025 with fourth quarter revenue of US$3.1b and Basic EPS of US$1.68, rounding out a trailing twelve month run of US$9.9b in revenue and Basic EPS of US$5.19. Over the past six reported quarters, revenue has moved from US$1.5b in Q3 2024 to US$3.1b in Q4 2025, while quarterly Basic EPS stepped from US$0.53 to US$1.68 as net income excluding extra items shifted from US$223m to US$855m. With trailing net profit margins sitting at 26.6% compared with 17.3% a...

If you are wondering whether Carpenter Technology's recent share price puts the stock on sale or already prices in a lot of optimism, the valuation story is worth a closer look. At a last close of US$445.14, the stock shows returns of 4.0% over 7 days, 13.0% over 30 days, 31.6% year to date and 113.4% over 1 year, with a very large 3 year and 5 year return profile. Recent coverage has focused on Carpenter Technology's role in capital goods and aerospace related markets, with attention on how...

Investors may be asking whether Principal Financial Group at around US$100 per share is offering fair value or a potential mispricing opportunity right now. The stock has recently seen a 0.9% decline over 7 days, compared with stronger returns of 9.9% over 30 days, 11.9% year to date, 31.8% over 1 year, 62.3% over 3 years and 83.4% over 5 years. Recent coverage has focused on how investors are reassessing insurers like Principal Financial Group in light of broader sector trends and shifting...

Stock performance snapshot MBX Biosciences (MBX) has caught investor attention recently, with the stock showing an 8.1% move in the last day and a 14.9% gain over the past month, alongside a 1-year total return near 196%. That kind of run, combined with a market value around US$1.53b and clinical stage programs in endocrine and metabolic disorders, puts the spotlight on how much future progress in its pipeline might already be reflected in the current share price. See our latest analysis for...